Current Opinion in Infectious Diseases was launched in 1988. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of infectious diseases is divided into 11 sections that are reviewed once a year. Each section is assigned to a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
José G. Montoya
Dr José G. Montoya is originally from Barranquilla, Colombia and he completed his medical degree with honors at Universidad del Valle in Cali, Colombia. He trained in Internal Medicine at Tulane University in New Orleans, USA. Following his residency, he completed a four-year intense fellowship training in Infectious Diseases under the mentorship of Drs Jack S. Remington and Thomas C. Merigan at Stanford University in Palo Alto, USA.
He is currently Professor in the Department of Medicine and Division of Infectious Diseases and Geographic Medicine at Stanford University School of Medicine. He is also the founder of the Immunocompromised Host Service (Infectious Diseases) at Stanford University Medical Center. He was elected Fellow of the American College of Physicians (FACP) in recognition of commitment to the internal medicine community and Fellow of the Infectious Diseases Society of America (FIDSA) for having achieved professional excellence in the field of Infectious Diseases
He is also the Director of the National Reference Laboratory for the Diagnosis and Management of Toxoplasmosis in the United States at the Palo Alto Medical Foundation in Palo Alto, California. He has authored and co-authored more than 180 publications in peer-reviewed journals along with book chapters. He has received more than 12 school-wide teaching awards at Stanford. For the past 15 years, his research endeavors have also included building a multidisciplinary team at Stanford University focused on elucidating the central pathogenesis of Myalgic Encephalomyelitis (ME), commonly known as Chronic Fatigue Syndrome (CFS) or ME/CFS and has created a world-class ME/CFS clinic visited by patients from all over the United States and abroad.
Trish M. Perl
Dr Trish M. Perl is a Chief of Infectious Diseases and the Jay P Sanford Professor of Medicine at the University of Texas Southwestern, Dallas, Texas, USA. Prior to this appointment she was Professor in the Departments of Medicine (Infectious Diseases) and Pathology at Johns Hopkins University School of Medicine in Baltimore, Maryland, USA and in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health.
Dr Perl received her Bachelor of Arts and Medical Degree from the University of North Carolina at Chapel Hill, North Carolina, USA, and a Master of Science degree from McGill University in Montreal, Canada. She completed an internship, residency, and fellowship in internal medicine at McGill (Royal Victoria Hospital) and a fellowship in infectious diseases and clinical epidemiology at the University of Iowa Hospitals and Clinics in Iowa City, Iowa, USA. She was the hospital epidemiologist of the Johns Hopkins Hospital between 1996 and 2010.
She has extensive practical and research experience in the field of healthcare associated infections and resistant organisms and is world renowned for her innovation and research in the field and the application of research knowledge in the healthcare setting. Dr Perl was the 2006 President of the Society of Hospital Epidemiologists of America (SHEA). In the past, she has served on advisory panels for the Institute of Medicine (IOM), the Centers for Disease Control (CDC) and World Health Organization (WHO) and has been a consultant to the National Institutes of Health (NIH) and Agency for Healthcare Research and Quality (ARHQ). An active researcher, Dr Perl has been a principal and co-principal investigator for studies on healthcare associated infections, bioterrorism syndromic surveillance, respiratory infections and antimicrobial resistance for the Centers for Disease Control and Prevention. She has authored or co-authored over 220 peer-reviewed articles. In addition, she has written multiple chapters and contributed to guidelines and policies relevant to healthcare associated infections at the institutional, state and federal level.
Dr Perl has been funded by the Centers for Disease Control and Prevention, the Veteran's Affairs Administration and Industry over the years. Her scientific interests encompass emerging diseases and planning in healthcare facilities for their management, syndromic surveillance, respiratory infections, healthcare associated infections including surgical site infections, Clostridium difficile, emerging infection prevention and interventions to prevent, the transmission of epidemiologically significant organisms, and patient and healthcare worker safety. She is committed to training fellows and others with interests in healthcare epidemiology and has begun working in the developing world to help promote the science and discovery in infection prevention.